Influence of polymorphism of the gene of inducible NO-synthase on the achievement of control of bronchial asthma in children against the background of inhalation corticosteroid therapy
https://doi.org/10.20538/1682-0363-2009-4-82-85
Abstract
The polymorphism of the gene of inducible NO-synthase (iNOS) was studied in 65 children with bronchial asthma (BA). The goal was to determine the probability to achieve the BA control in children against the background of inhalation glucocorticosteroid (IGCS) therapy depending on the polymorphism of the iNOS gene. The genotype of polymorphism of the iNOS gene was studied by the method of polymerase chain reaction. It has been found that the achievement of BA control in children against the background of the IGCS treatment is associated with the carriage of homozygote of «wild» allele G of polymorphism G954C of the iNOS gene. The absence of BA control is related to the presence of pathological allele . The result obtained can favor the pre С - diction of the uncontrollable BA course in children.
About the Authors
I. Yu. Smirnova
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
I. V. Petrova
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
I. A. Deyev
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
References
1. Геппе Н.А., Соодаева С.К., Белоусова Е.Г. и др. Оксид азота как маркер воспаления при бронхиальной астме//Вопр. практ. педиатрии. 2007 Т. 2, № 4. С. 27-31.
2. Глобальная стратегия лечения и профилактики бронхиальной астмы/под ред. А.Г. Чучалина. М.: ИД «Атмосфера», 2007. 104 с.
3. Жданова М.В., Богданова М.А., Войтович А.Н. и др. Особенности течения бронхиальной астмы у детей с различными генотипами BclI полиморфизма гена глюкокортикоидного рецептора//Педиатрия им. Г.Н. Сперанского. 2007. Т. 86, № 4. С. 19-24.
4. Ляпунов А.А., Балаболкин И.И., Реутова В.С. и др. Клиническое значение исследования оксида азота в выдыхаемом воздухе у детей с бронхиальной астмой//Педиатрия. 2003. № 6. C. 1-4.
5. Макарова И.В. Сравнительная эффективность применения беклазона в двух системах доставки при бронхиальной астме у детей: ДАИ и ДАИ «Легкое дыхание»//Аллергология. 2002. № 4. С. 16-19.
6. Ahluwalia A. Topical glucocorticoids and the skin -mechanisms of action: an update//Mediators of Inflammation. 1998. V. 7. P. 193-197.
7. Mulrennan S.A. Redington A.E. Nitric oxide synthase inhibition: therapeutic potential in asthma//Treat Respir. Med. 2004. V. 3. P. 79-88.
8. Pitt B. R., Croix Cl. Complex Regulation of iNOS in Lung//Am. J. Respir. Cell. Mol. Biol. 2002. V. 26. P. 6-9.
9. Ricciardolo F.L.M., Sterk P.J., Gaston B. et al. Nitric oxide in health and disease of the respiratory system//Physiol. Rev. 2004. V. 84. P. 731-765.
10. Xiong Y. Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase//J. Immunol. 1999. V. 162. P. 445-452.
Review
For citations:
Smirnova I.Yu., Petrova I.V., Deyev I.A. Influence of polymorphism of the gene of inducible NO-synthase on the achievement of control of bronchial asthma in children against the background of inhalation corticosteroid therapy. Bulletin of Siberian Medicine. 2009;8(4):82-85. (In Russ.) https://doi.org/10.20538/1682-0363-2009-4-82-85
Views:
509
Email this article 